Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
- PMID: 33572802
- PMCID: PMC7912523
- DOI: 10.3390/biom11020185
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
Abstract
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or Systemic Exertion Intolerance Disease (SEID) is a chronic multisystem illness of unconfirmed etiology. There are currently no biomarkers and/or signatures available to assist in the diagnosis of the syndrome and while numerous mechanisms have been hypothesized to explain the pathology of ME/CFS, the triggers and/or drivers remain unknown. Initial studies suggested a potential role of the human herpesviruses especially Epstein-Barr virus (EBV) in the disease process but inconsistent and conflicting data led to the erroneous suggestion that these viruses had no role in the syndrome. New studies using more advanced approaches have now demonstrated that specific proteins encoded by EBV could contribute to the immune and neurological abnormalities exhibited by a subgroup of patients with ME/CFS. Elucidating the role of these herpesvirus proteins in ME/CFS may lead to the identification of specific biomarkers and the development of novel therapeutics.
Keywords: BLLF3; BRRF1; deoxyuridine triphosphate nucleotidohydrolase (dUTPase); epstein-barr virus (EBV); human herpesvirus 6 (HHV-6); immune dysfunction; myalgic encephalomyelitis/chronic fatigue syndrome.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Clin Ther. 2019 May;41(5):848-863. doi: 10.1016/j.clinthera.2019.04.009. Epub 2019 Apr 28. Clin Ther. 2019. PMID: 31040055 Free PMC article.
-
Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.J Med Virol. 2017 Sep;89(9):1636-1645. doi: 10.1002/jmv.24810. Epub 2017 Apr 26. J Med Virol. 2017. PMID: 28303641 Free PMC article.
-
EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.JCI Insight. 2022 Jun 8;7(11):e158193. doi: 10.1172/jci.insight.158193. JCI Insight. 2022. PMID: 35482424 Free PMC article.
-
Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.Front Immunol. 2021 Nov 15;12:656797. doi: 10.3389/fimmu.2021.656797. eCollection 2021. Front Immunol. 2021. PMID: 34867935 Free PMC article. Review.
-
Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Biomolecules. 2020 Oct 26;10(11):1484. doi: 10.3390/biom10111484. Biomolecules. 2020. PMID: 33114612 Free PMC article. Review.
Cited by
-
Improvement Effects of Myelophil on Symptoms of Chronic Fatigue Syndrome in a Reserpine-Induced Mouse Model.Int J Mol Sci. 2021 Sep 22;22(19):10199. doi: 10.3390/ijms221910199. Int J Mol Sci. 2021. PMID: 34638540 Free PMC article.
-
Cytokine Deficiencies in Patients with Long-COVID.J Clin Cell Immunol. 2022;13(6):672. Epub 2022 Nov 18. J Clin Cell Immunol. 2022. PMID: 36742994 Free PMC article.
-
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.Viruses. 2023 Jan 31;15(2):400. doi: 10.3390/v15020400. Viruses. 2023. PMID: 36851614 Free PMC article. Review.
-
Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.Front Med (Lausanne). 2021 Jul 5;8:686736. doi: 10.3389/fmed.2021.686736. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34291062 Free PMC article.
-
Pre-assessment and management of long COVID patients requiring elective surgery: challenges and guidance.Perioper Med (Lond). 2023 Jun 5;12(1):20. doi: 10.1186/s13741-023-00305-3. Perioper Med (Lond). 2023. PMID: 37277879 Free PMC article.
References
-
- Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994;121:953–959. doi: 10.7326/0003-4819-121-12-199412150-00009. - DOI - PubMed
-
- Carruthers B.M., Jain A.K., De Meirleir D.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.C., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J. CFS. 2003;11:7–115. doi: 10.1300/J092v11n01_02. - DOI
-
- Carruthers B.M., van de Sande M., De Meirleir D.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International consensus criteria. J. Intern. Med. 2011;270:327–338. doi: 10.1111/j.1365-2796.2011.02428.x. - DOI - PMC - PubMed
-
- Institute of Medicine (U.S.) Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Institute of Medicine (U.S.) Board on the Health of Select Populations. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies Press; Washington, DC, USA: 2015.
-
- Monro J.A., Puri B.K. A molecular neurobiological approach to understanding the aetiology of Chronic Fatigue Syndrome (Myalgic Encephalomyelitis or Systemic Exertion Intolerance Disease with treatment implications. Mol. Neurobiol. 2018;55:7377–7388. doi: 10.1007/s12035-018-0928-9. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical